Prescription Stimulant Nonmedical Use Among Adolescents Evaluated for Substance Use Disorder Treatment (CHAT™)
| Autor: | Jeffrey H. Newcorn, Robert L. Findling, Jody L. Green, Stephen F. Butler, Anthony L. Rostain, Suzanne K. Vosburg, Taryn Dailey Govoni, Stephen V. Faraone |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
medicine.medical_specialty
Adolescent Substance-Related Disorders medicine.medical_treatment 05 social sciences medicine.disease Stimulant Substance abuse 03 medical and health sciences Clinical Psychology 0302 clinical medicine Prescriptions Attention Deficit Disorder with Hyperactivity Developmental and Educational Psychology medicine Humans 0501 psychology and cognitive sciences Central Nervous System Stimulants Medical prescription Substance use Psychology Psychiatry 030217 neurology & neurosurgery Prescription Drug Misuse 050104 developmental & child psychology |
| Zdroj: | Journal of attention disorders. 25(13) |
| ISSN: | 1557-1246 |
| Popis: | Objective: The purpose of the present study was to characterize prescription stimulant non-medical use (NMU) in adolescents between the ages of 13 and 18 years seeking treatment for substance use disorder (SUD) with the Comprehensive Health Assessment Tool for Teens (CHAT™). Method: Adolescents being evaluated for SUD treatment between Q1 2010 and Q3 2017 ( n = 20,189) completed the CHAT™. Results: About 4.3% of the sample ( N = 867) of adolescents in SUD treatment reported past 30-day prescription stimulant NMU. Compared to those without past 30-day prescription stimulant NMU, more reported a lifetime diagnosis of learning disorder or ADHD, more took medication for emotional, behavioral, or learning disorders, received past-month inpatient treatment, or were currently not enrolled in school. Prescription stimulants were most often taken orally for NMU, however, approximately half reported using alternate routes of administration, the most prominent of which was intranasal use. Conclusion: About 4.3% of adolescents in SUD treatment evaluation reported past 30-day prescription stimulant NMU. Greater percentages of lifetime learning disorder, medication use, past-month inpatient treatment, school unenrollment, and overall substance misuse were associated with prescription stimulant NMU, as were alternate routes of administration. These data reveal an ongoing, persistent level of past-30-day NMU of prescription stimulants among adolescents being evaluated for SUD treatment. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|